DexCom (NASDAQ: DXCM) reported Q2 EPS of ($0.10), $0.08 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $242.5 million versus the consensus estimate of $205.68 million.

GUIDANCE:

DexCom sees FY2018 revenue of $925 million, versus the consensus of $862.2 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.